BRISTOL MYERS SQUIBB CO (BMY) is a Health Care company in the Pharmaceutical Preparations industry (SEC CIK 0000014272). Annual revenue was $48.19B in FY2025, compared to $46.38B in FY2021. Net income in FY2025 was $7.05B (diluted EPS $3.46).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Gross Profit | $34.26B | $34.33B | $34.31B | $36.02B | $36.45B |
| Operating Income | — | — | — | — | — |
| Net Income | $7.05B | negative: -$8.95B | $8.03B | $6.33B | $6.99B |
| EPS (Diluted) | $3.46 | negative: -$4.41 | $3.86 | $2.95 | $3.12 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.16B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 71.1% |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001140361-26-020036 | May 5, 2026 | May 8, 2026 | May 8, 2026 20:10 UTC | EDGAR |
| 8-K | 0000014272-26-000008 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 11:01 UTC | EDGAR |
| 10-Q | 0000014272-26-000010 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 15:44 UTC | EDGAR |
| 10-K | 0000014272-26-000004 | Dec 31, 2025 | Feb 11, 2026 | Feb 11, 2026 16:35 UTC | EDGAR |
| 8-K | 0000014272-26-000002 | Feb 5, 2026 | Feb 5, 2026 | Feb 5, 2026 12:07 UTC | EDGAR |
| 8-K | 0001140361-26-000929 | Jan 12, 2026 | Jan 12, 2026 | Jan 12, 2026 15:20 UTC | EDGAR |
| 8-K | 0001140361-25-042607 | Nov 17, 2025 | Nov 18, 2025 | Nov 18, 2025 21:41 UTC | EDGAR |
| 8-K | 0001140361-25-041380 | Oct 31, 2025 | Nov 10, 2025 | Nov 10, 2025 21:06 UTC | EDGAR |
Direct links to SEC EDGAR. BMY has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $92.60B |
| $95.16B |
| $96.82B |
| $109.31B |
| Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B |
|---|
| Stockholders' Equity | $18.51B | $16.39B | $29.48B | $31.12B | $36.01B |
|---|
| Cash & Equivalents | $10.21B | $10.35B | $11.52B | $9.32B | $14.32B |
|---|
| Total Debt | — | — | $4.50B | $6.00B | — |
|---|
| $15.19B |
| $13.86B |
| $13.07B |
| $16.21B |
| Capital Expenditures | $1.31B | $1.25B | $1.21B | $1.12B | $0.97B |
|---|
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
|---|
| 76.2% |
| 78.0% |
| 78.6% |
| Operating Margin | 0.3% | negative: -0.1% | 0.1% | 0.2% | 0.2% |
|---|
| Net Margin | 0.1% | negative: -0.2% | 0.2% | 0.1% | 0.2% |
|---|
| Return on Equity | 40.4% | negative: -39.0% | 26.5% | 18.9% | 18.9% |
|---|
| Return on Assets | 7.7% | negative: -9.5% | 8.4% | 6.1% | 6.1% |
|---|
| Debt / Equity | 2.65× | 3.25× | 0.15× | 0.19× | 1.50× |
|---|
